Sivia Capital Partners’s Gossamer Bio GOSS Stock Holding History

Sivia Capital Partners’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1K	Buy	1,904 +758	+66%	+$16.9K	﹤0.01%	539
2026 Q1	$30.1K	Buy	1,146 +708	+162%	+$89K	0.01%	453
2025 Q4	$109K	Buy	438 +49	+13%	+$11.2K	0.02%	542
2025 Q3	$81.9K	Buy	389 +14	+4%	+$2.47K	0.02%	463
2025 Q2	$36.9K	Hold	375	–	–	0.01%	432
2025 Q1	$33K	Buy	375 +25	+7%	+$2.31K	0.02%	291
2024 Q4	$25.3K	Sell	350 -138	-28%	-$9.46K	0.01%	204
2024 Q3	$38.5K	Buy	488 +50	+11%	+$3.85K	0.02%	214
2024 Q2	$31.5K	Buy	438 +131	+43%	+$7.84K	0.02%	194
2024 Q1	$29K	Buy	+307	New	+$27K	0.02%	189

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Sivia Capital Partners's GOSS Position: Q2 2026 in Review

Sivia Capital Partners increased its Gossamer Bio (GOSS) stake by 66% in Q2 2026, buying an estimated $16.9K and bringing the position to 1,904 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Sivia Capital Partners first reported a position in GOSS in Q1 2024 and has held it in 10 quarters since. The position peaked at $109K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Sivia Capital Partners held 1,904 shares of Gossamer Bio worth $25.1K as of Q2 2026.
Sivia Capital Partners bought 758 Gossamer Bio shares in Q2 2026, an estimated $16.9K.
Gossamer Bio made up ﹤0.01% of Sivia Capital Partners's portfolio in Q2 2026, its #539 holding.
Sivia Capital Partners first reported a position in Gossamer Bio in Q1 2024 and has held it in 10 quarters since.
Sivia Capital Partners's Gossamer Bio position peaked at $109K in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.